219 related articles for article (PubMed ID: 21990283)
1. Letting the sunshine in on doctor-pharma relationships.
Jack A
BMJ; 2011 Oct; 343():d6459. PubMed ID: 21990283
[No Abstract] [Full Text] [Related]
2. Letting the sunshine in: shining a new light on physician-industry relationships.
Bruguera CM; Hirsch JA
J Neurointerv Surg; 2010 Mar; 2(1):80-2. PubMed ID: 21990565
[TBL] [Abstract][Full Text] [Related]
3. Doctors and drug companies--scrutinizing influential relationships.
Campbell EG
N Engl J Med; 2007 Nov; 357(18):1796-7. PubMed ID: 17978288
[No Abstract] [Full Text] [Related]
4. Shining a light on the Sunshine Act.
Peck AA
J Med Assoc Ga; 2013; 102(2):28. PubMed ID: 24006732
[No Abstract] [Full Text] [Related]
5. Already feeling the heat: Docs rethinking payments as Sunshine Act looms.
Lee J
Mod Healthc; 2013 Jul; 43(26):12-3. PubMed ID: 23878901
[No Abstract] [Full Text] [Related]
6. Cash interests taint drug advice.
Taylor R; Giles J
Nature; 2005 Oct; 437(7062):1070-1. PubMed ID: 16237402
[No Abstract] [Full Text] [Related]
7. An MS patient loses trust when she finds out her doctor is paid by drug companies.
Wolston M
Health Aff (Millwood); 2011 Dec; 30(12):2449-52. PubMed ID: 22147873
[No Abstract] [Full Text] [Related]
8. US to require public disclosure of drug and device industry's financial ties to doctors.
Epstein K
BMJ; 2012 Jan; 344():e515. PubMed ID: 22262802
[No Abstract] [Full Text] [Related]
9. Transparency urged over research payments.
Check E
Nature; 2007 Aug; 448(7155):738. PubMed ID: 17700667
[No Abstract] [Full Text] [Related]
10. Financial conflicts of interest in physicians' relationships with the pharmaceutical industry--self-regulation in the shadow of federal prosecution.
Studdert DM; Mello MM; Brennan TA
N Engl J Med; 2004 Oct; 351(18):1891-900. PubMed ID: 15509824
[No Abstract] [Full Text] [Related]
11. Let the sunshine in--making industry payments to New Zealand doctors transparent.
Farquhar C; Stokes T; Grey A; Jeffery M; Griffin P
N Z Med J; 2015 Mar; 128(1411):6-12. PubMed ID: 25820497
[No Abstract] [Full Text] [Related]
12. Managing physician financial conflicts of interest in clinical trials conducted in the private practice setting.
Williams KM
Food Drug Law J; 2004; 59(1):45-77. PubMed ID: 15190925
[No Abstract] [Full Text] [Related]
13. Two years of sunshine: has openness about payments reduced industry influence in healthcare?
Lenzer J
BMJ; 2016 Aug; 354():i4608. PubMed ID: 27562781
[No Abstract] [Full Text] [Related]
14. Sunlight as disinfectant--new rules on disclosure of industry payments to physicians.
Rosenthal MB; Mello MM
N Engl J Med; 2013 May; 368(22):2052-4. PubMed ID: 23718162
[No Abstract] [Full Text] [Related]
15. Author Self-disclosure Compared with Pharmaceutical Company Reporting of Physician Payments.
Alhamoud HA; Dudum R; Young HA; Choi BG
Am J Med; 2016 Jan; 129(1):59-63. PubMed ID: 26169886
[TBL] [Abstract][Full Text] [Related]
16. The Sunshine Act--effects on physicians.
Agrawal S; Brennan N; Budetti P
N Engl J Med; 2013 May; 368(22):2054-7. PubMed ID: 23718163
[No Abstract] [Full Text] [Related]
17. Big bad pharma: an ethical analysis of physician-directed and consumer-directed marketing tactics.
Connors AL
Albany Law Rev; 2009 Sep; 73(1):243-82. PubMed ID: 20235401
[No Abstract] [Full Text] [Related]
18. Physician payment sunshine act.
Merino JG
BMJ; 2013 Aug; 347():f4828. PubMed ID: 23908473
[No Abstract] [Full Text] [Related]
19. New rules on conflict of interest: what has to be done in Europe?
Jirillo A; Vascon F
Tumori; 2010; 96(1):180-1. PubMed ID: 20437882
[No Abstract] [Full Text] [Related]
20. Information disclosure and the Physician Payments Sunshine Act.
Kimball AB
JAMA; 2011 Sep; 306(10):1087; author reply 1087-8. PubMed ID: 21917577
[No Abstract] [Full Text] [Related]
[Next] [New Search]
